FDA Adverse Event Injury Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1923376 · Received December 13, 2010

Report

Report Number
2024168-2010-02698
Event Type
Injury
Date Received
December 13, 2010
Date of Event
March 23, 2009
Report Date
November 19, 2010
Manufacturer
AV-TEMECULA
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT INFORMATION; HOWEVER, IT WAS NOT POSSIBLE TO PERFORM A THOROUGH ANALYSIS ON THE DEVICE BECAUSE IT WAS NOT RETURNED FOR EVALUATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. DISSECTION IS A KNOWN ADVERSE EVENT AS LISTED IN THE PROMUS INSTRUCTIONS FOR USE (IFU). ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING THE PROCEDURE IN THE PROXIMAL RIGHT CORONARY ARTERY A 3.0X28 RX PROMUS STENT WAS IMPLANTED. A GRADE F DISSECTION OCCURRED DISTAL TO THE TARGET LESION. THE DISSECTION WAS TREATED WITH THE PLACEMENT OF TWO ADDITIONAL RX PROMUS STENTS, A 3.0 X 12 MM AND A 3.0 X 28 MM. FOLLOWING POST-DILATATION, THERE WAS 0% RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECTS. THE PATIENT WAS DISCHARGED ON (B)(6) 2009 WITH ASPIRIN AND CLOPIDOGREL PRESCRIBED. PER PHYSICIAN, THE RELATIONSHIP OF THE ADVERSE EVENT TO THE INDEX PROCEDURE IS HIGHLY PROBABLE. NO ADDITIONAL INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA 8100761

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention RX PROMUS STENTS 3.0X12 & 3.0X28